Three ASX 200 Stocks Propel Market Gains This Week

2 min read | November 08, 2024 03:14 PM AEDT | By Team Kalkine Media

Google News:

Three ASX 200 Stocks Propel Market Gains This Week — Image source: Shutterstock

Recent News

Santos (ASX:STO) After the Takeover Collapse: Bargain or Value Trap?

Why Pro Medicus (ASX:PME) Is Leading the Growth Stock Conversation

Is 360 (ASX:360) Amid ASX 200 Revealing Growth’s New Reality?

Why 360 (ASX:360) ASX 200 Is Facing a New Growth Test

Make Kalkine Media
My Trusted Source

Highlights:

Neuren Pharmaceuticals Leads the Week: Neuren Pharmaceuticals (ASX:NEU) saw a 33.8% increase in its share price following positive updates and a significant lump-sum payment.

Sigma Healthcare's Strong Performance: Sigma Healthcare (ASX:SIG) rose by 32.4%, bolstered by the ACCC's approval of its merger with Chemist Warehouse.

Tabcorp Shows Solid Gains: Tabcorp Holdings (ASX:TAH) saw a 14.3% increase in its share price despite challenges, signaling potential market confidence.

The S&P/ASX 200 Index (ASX:XJO) experienced a strong week, with notable gains across several stocks. As of Friday afternoon, three stocks stood out for their impressive performances, with gains ranging from 14% to 33%.

Neuren Pharmaceuticals Ltd (ASX:NEU) was the top performer, rising by 33.8% over the week. The biopharma company saw its share price surge after announcing a $50 million (AU$76 million) payment from its U.S. partner, Acadia Pharmaceuticals. Additionally, Neuren's third-quarter trading update, released later in the week, helped sustain positive sentiment. Despite not paying dividends, Neuren's strong growth potential continues to attract market attention.

Sigma Healthcare Ltd (ASX:SIG), a pharmacy chain operator, was another strong performer, with its shares increasing by 32.4% in just one week. A significant part of this rise came after the Australian Competition & Consumer Commission (ACCC) announced it would not oppose Sigma’s planned merger with Chemist Warehouse. This news led to a 24.9% jump in Sigma's share price on Thursday. The company's share price has seen a remarkable 293% increase over the past year, making it one of the standout performers in the healthcare sector.

Tabcorp Holdings Ltd (ASX:TAH), a major player in the Australian gambling sector, also saw a solid performance with a 14.3% increase in its share price. Although the stock remained down 36% over the past year, the recent recovery may be driven by market optimism regarding the Australian economy's performance and potential future interest rate cuts.

In summary, these three ASX 200 stocks—Neuren Pharmaceuticals, Sigma Healthcare, and Tabcorp—have each demonstrated strong growth, driven by specific corporate developments and broader market factors.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.